MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$34,400K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation expense
Proceeds from exercise of common...
Non-cash operating lease expense
Others
Negative Cash Flow Breakdown
Change in fair value of warrant ...
Net loss
Accrued expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Net loss
-16,320
-43,727
-45,603
-51,624
Depreciation
559
279
290
560
Non-cash interest expense
127
69
72
155
Non-cash operating lease expense
860
413
400
774
Stock-based compensation expense
5,027
1,855
1,638
3,191
Change in fair value of warrant liabilities
-24,571
20,177
21,201
-477
Change in fair value of notes payable, non-cash
-140
-184
785
-177
Inventory
-
0
0
-73
Prepaid expenses and other current assets
484
-68
-2,351
171
Accounts payable
-568
318
-2,655
671
Accrued expenses and other current liabilities
-1,888
-169
-811
1,394
Operating lease liabilities
-770
-355
-318
-605
Other long-term assets and liabilities
210
80
64
42
Net cash used in operating activities
-38,378
-21,336
-22,714
-46,278
Purchases of property and equipment
-
3
8
546
Net cash used in investing activities
-
-3
-8
-546
Exercises of common stock options
-
0
0
280
Proceeds from initial public offering, net of underwriting discounts and commissions
-
-
0
0
Issuance of common stock in connection with at-the-market offering, net of underwriting commissions and offering costs
-
4,709
477
1,592
Issuance of common stock and warrants in august 2025 public offering, net of underwriting commissions and offering costs
-
1,259
21,328
-
Issuance of common stock in september 2025 public offering, net of underwriting commissions and offering costs
-
-384
56,400
-
Proceeds from issuance of common stock under share purchase agreement
-
20
-
-
Proceeds from exercise of common stock warrants
4,058
19,737
-
-
Proceeds from issuance of common stock under employee stock purchase plan
170
-
-
-
Principal payments on finance lease obligations
250
119
117
221
Net cash provided by financing activities
3,978
25,222
78,088
1,651
Net increase (decrease) in cash, cash equivalents and restricted cash
-34,400
3,883
55,366
-45,173
Cash, cash equivalents and restricted cash at beginning of period
85,795
81,912
71,719
-
Cash, cash equivalents and restricted cash at end of period
51,395
85,795
81,912
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from exercise of
common stock warrants
$4,058K
Proceeds from issuance of
common stock under...
$170K
Net cash provided by
financing activities
$3,978K
(140.94%↑ Y/Y)
Canceled cashflow
$250K
Net increase
(decrease) in cash, cash...
-$34,400K
(23.85%↑ Y/Y)
Canceled cashflow
$3,978K
Stock-based compensation
expense
$5,027K
(57.54%↑ Y/Y)
Non-cash operating lease
expense
$860K
(11.11%↑ Y/Y)
Depreciation
$559K
(-0.18%↓ Y/Y)
Non-cash interest
expense
$127K
(-18.06%↓ Y/Y)
Principal payments on
finance lease...
$250K
(13.12%↑ Y/Y)
Net cash used in
operating activities
-$38,378K
(17.07%↑ Y/Y)
Canceled cashflow
$6,573K
Change in fair value of
warrant liabilities
-$24,571K
(-5051.15%↓ Y/Y)
Net loss
-$16,320K
(68.39%↑ Y/Y)
Accrued expenses and
other current...
-$1,888K
(-235.44%↓ Y/Y)
Operating lease
liabilities
-$770K
(-27.27%↓ Y/Y)
Accounts payable
-$568K
(-184.65%↓ Y/Y)
Prepaid expenses and
other current assets
$484K
(183.04%↑ Y/Y)
Other long-term
assets and liabilities
$210K
(400.00%↑ Y/Y)
Change in fair value of
notes payable,...
-$140K
(20.90%↑ Y/Y)
Buy us a coffee
FRACTYL HEALTH, INC. (GUTS)
FRACTYL HEALTH, INC. (GUTS)